SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-057299
Filing Date
2022-09-20
Accepted
2022-09-20 13:13:58
Documents
15
Period of Report
2022-09-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166064-8k_inmedpharma.htm   iXBRL 8-K 30384
2 NEWS RELEASE, DATED SEPTEMBER 19, 2022 ea166064ex99-1_inmedpharma.htm EX-99.1 11375
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5094
  Complete submission text file 0001213900-22-057299.txt   264420

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20220919.xsd EX-101.SCH 3470
5 XBRL DEFINITION FILE inm-20220919_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20220919_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20220919_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea166064-8k_inmedpharma_htm.xml XML 4173
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221252870
SIC: 2834 Pharmaceutical Preparations